CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Cancer Research and Treatment. 2019;51(2):502-509.   Published online 2018 June 13    DOI: https://doi.org/10.4143/crt.2018.117

Excel Download

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Cancer Research and Treatment. 2019;51(2):502-509   Crossref logo
Link1 Link2 Link3

Afatinib/erlotinib/gefitinib
Reactions Weekly. 2018;1705(1):15-15   Crossref logo
Link1 Link2 Link3

Afatinib in EGFR mutant non-small-cell carcinoma: Milton Keynes experience
Lung Cancer. 2020;139:S44   Crossref logo
Link1 Link2

Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer
Lung Cancer. 2007;58(3):414-417   Crossref logo
Link1 Link2

Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
Value in Health. 2016;19(7):A740-A741   Crossref logo
Link1 Link2

Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer
Lung Cancer. 2010;69(3):259-264   Crossref logo
Link1 Link2

Afatinib/erlotinib/gefitinib
Reactions Weekly. 2021;1847(1):27-27   Crossref logo
Link1 Link2 Link3

Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
OncoTargets and Therapy. 2015;1137   Crossref logo
Link1

Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer
Lung Cancer. 2016;99:1-3   Crossref logo
Link1 Link2

Efficacy and Safety of Gefitinib or Platinum plus Taxane in Egfr-Mutant Advanced Non-Small Cell Lung Cancers: A Meta-Analysis of First-Line Randomized Controlled Trials
Journal of Cancer Therapy. 2012;03(04):467-476   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.